Vertex Pharmaceuticals (VRTX) Cash from Investing Activities Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -674.01% |
| Dec 31, 2025 | 64.95% |
| Sep 30, 2025 | 66.38% |
| Jun 30, 2025 | -4.49% |
| Mar 31, 2025 | 97.39% |
| Dec 31, 2024 | 7.29% |
| Sep 30, 2024 | -195.67% |
| Jun 30, 2024 | -52.58% |
| Mar 31, 2024 | -16.51% |
| Dec 31, 2023 | -604.84% |
| Sep 30, 2023 | 69.36% |
| Jun 30, 2023 | -394.15% |
| Mar 31, 2023 | -3,495.29% |
| Dec 31, 2022 | 231.04% |
| Sep 30, 2022 | -626.28% |
| Jun 30, 2022 | 22.84% |
| Mar 31, 2022 | 31.36% |
| Dec 31, 2021 | -154.97% |
| Sep 30, 2021 | 78.66% |
| Jun 30, 2021 | -210.83% |
| Mar 31, 2021 | -334.64% |
| Dec 31, 2020 | 127.18% |
| Sep 30, 2020 | 0.43% |
| Jun 30, 2020 | 243.28% |
| Mar 31, 2020 | 180.91% |
| Dec 31, 2019 | -2,092.87% |
| Sep 30, 2019 | -399.11% |
| Jun 30, 2019 | 56.84% |
| Mar 31, 2019 | -893.39% |
| Dec 31, 2018 | -96.79% |
| Sep 30, 2018 | 77.85% |
| Jun 30, 2018 | -52.46% |
| Mar 31, 2018 | 103.06% |
| Dec 31, 2017 | -111.75% |
| Sep 30, 2017 | -747.53% |
| Jun 30, 2017 | -32.02% |
| Mar 31, 2017 | -56.73% |
| Dec 31, 2016 | 244.21% |
| Sep 30, 2016 | 134.47% |
| Jun 30, 2016 | -120.75% |
| Mar 31, 2016 | -147.99% |
| Dec 31, 2015 | -581.19% |
| Sep 30, 2015 | -430.45% |
| Jun 30, 2015 | 209.79% |
| Mar 31, 2015 | 1,148.85% |
| Dec 31, 2014 | 84.97% |
| Sep 30, 2014 | -38.34% |
| Jun 30, 2014 | 2,016.05% |
| Mar 31, 2014 | 45.72% |
| Dec 31, 2013 | -1,774.26% |
| Sep 30, 2013 | 137.75% |
| Jun 30, 2013 | 93.30% |
| Mar 31, 2013 | 83.77% |
| Dec 31, 2012 | 101.85% |
| Sep 30, 2012 | -711.90% |
| Mar 31, 2012 | -157.08% |
| Dec 31, 2011 | -128.51% |
| Sep 30, 2011 | 988.40% |
| Mar 31, 2011 | 192.55% |
| Dec 31, 2010 | 69.02% |
| Sep 30, 2010 | -105.68% |
| Jun 30, 2010 | 148.59% |
| Mar 31, 2010 | 73.07% |